The Alliance for Regenerative Medicine (ARM) has released its first quarter industry report that describes a regenerative medicine sector, which includes gene and cellular therapies, in healthy shape. Growth is evident on a number of fronts, even in the wake of the uncertain financial environment that has prevailed and depressed the capital market since the beginning of the year. Read More
Having large databases can be helpful in making discoveries not obvious in smaller datasets, but getting the data into a compatible format and then actually using the “big data” in a meaningful manner can be challenging. Read More
